We invite you to attend the South Atlantic Association of Obstetricians and Gynecologists 2023 Annual Meeting taking place January 28 - 31, 2023 at The Omni Grove Park Inn in Asheville, NC. The 2023 Annual Meeting will provide practicing Ob/Gyns and REI Physicians educational opportunities on new scientific applications and technologic advances in the field.
In addition to the educational offerings, there will be numerous opportunities for attendees to connect with colleagues and network during exhibit hall social functions. The exhibit hall will feature the most prominent industry leaders in the field of Ob/Gyn and REI showcasing their best products and services. We encourage all attendees to make their reservations as soon as possible. Please visit the venue tab for more information on discounted rates and to book your room.
The Omni Grove Park Inn
290 Macon Ave, Asheville, NC 28804
The Omni Grove Park Inn and The South Atlantic Association of Obstetricians and Gynecologists look forward to welcoming you to Asheville! Here you will find important information for your stay:
Check-in: 4:00 pm / Check-out: 11:00 am
Self-Parking: $25 per night
Valet: $35 per night
The Omni Grove Park Inn has some of the finest, locally-sourced restaurants in Asheville that will certainly delight any foodie. For more information on dinning options at the Omni, please visit: Dining at The Omni Grove Park Inn
The Spa at Omni Grove Park Inn Hours of Operation:
Thursday: 8:00 a.m. to 6:00 p.m.
Friday - Saturday: 8:00 a.m. to 7:00 p.m.
Explore all that the spa has to offer by visiting: The Spa at The Omni Grove Park Inn
For a complete list of everything that the property has to offer, check out the Omni Grove Park Inn Resort Guide
Full notification of commercial support will be provided in the activity accreditation.
This program has been designed to meet the educational needs of physicians who have a specialized interest in the field of obstetrics and gynecology.
At the conclusion of this activity, the attendee can expect to be able to:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The American College of Obstetricians and Gynecologists and South Atlantic Association of Obstetricians and Gynecologists. The American College of Obstetricians and Gynecologists is accredited by the ACCME to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)™
The American College of Obstetricians and Gynecologists designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
College Cognate Credit(s)
The American College of Obstetricians and Gynecologists designates this live activity for a maximum of 12.5 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits™ to be equivalent to College Cognate Credits.
DISCLOSURE OF FACULTY AND INDUSTRY RELATIONSHIPS
In accordance with College policy, all faculty and planning committee members have signed a conflict of interest statement in which they have disclosed any financial interests or other relationships with ineligible companies relative to topics they will discuss at this program. At the beginning of the program, faculty members are required to disclose any such information to participants. Such disclosure allows you to evaluate better the objectivity of the information presented in lectures. Please report on your evaluation form any undisclosed conflict of interest you perceive.
RELEVANT FINANCIAL RELATIONSHIPS: FACULTY/PLANNING COMMITTEE MEMBERS/REVIEWERS/STAFF ALL RELEVANT FINANCIAL RELATIONSHIPS HAVE BEEN MITIGATED
|Haywood Brown, MD||“Consultant: Myriad; Medical Advisor: Access to Equity Carrier Screening Coalition; Co PI: AIM CCI HRSA Postpartum; Advisory Board: Merck for Mothers Global Health”|
|Stephen Bush, MD||“Teaching Faculty: Applied Medical”|
|Paul Dietz, MD||“Trainer: Organon”|
|Cheryl Iglesia, MD||“Scientific Advisory Board: Healthy Women Foundation; Medical Advisory Board: Patty Brisben Foundation; SGE Special Govt Employee, OB/GYN Devices Panel: US FDA; Chair, NICHD Pelvic Floor Disorders Network Advisory Board; President, Executive Board Member: Society Gynecologic Surgeons”|
|Andrew Kauntiz, MD||“Consultant: Mithra and Myovant”|
|Barbara Levy, MD||“Consultant: Abbvie and Hologic”|
|Joann Pinkerton, MD||“PI for Multicenter Clinical Trial: Bayor”|
ALL OTHER FACULTY/PLANNING COMMITTEE MEMBERS/REVIEWERS/STAFF HAVE NO RELEVANT FINANCIAL RELATIONSHIPS WITH INELIGIBLE COMPANIES
CRITERIA FOR SUCCESS
Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form. A statement of credit will be issued within 4-6 weeks of participant’s completion of an online evaluation/claimed credit form at www.saaog.org/cme. Please contact firstname.lastname@example.org should you have any questions.
SATURDAY, JANUARY 28
WELCOME RECEPTION | 6:00 – 7:00pm
Location: Exhibit Hall, Grand Ballroom BC
Complimentary for attendees; $115/guest(s)
Join your colleagues and the 2023 exhibitors and supporters for an opening reception on Saturday evening in the exhibit hall. Interact with exhibiting companies and enjoy tasty hors d’oeuvres and cocktails. Please note that all guests must have a purchased guest badge. You can purchase a guest badge at the SAAOG Registration Desk in the Grand Ballroom Foyer.
SUNDAY, JANUARY 29
EXPERT THEATER | 9:55–10:45am
Location: Eisenhower FG
OvaSuite: Complete Ovarian Cancer Risk Assessment Portfolio for Women with Adnexal Masses Sponsored by Aspira Women’s Health
BLACK TIE DINNER AND DANCE | 6:30 – 11:00pm
Buy your tickets now to attend the highlighted event of the meeting! SAAOG will celebrate its 85th Annual Meeting with a formal waited dinner, accompanied by live music and dancing. Dinner guests will be treated to a pre-dinner cocktail located under a twilight sky to get the evening started. Here you can mingle with old friends, interact with colleagues and meet fellow attendees. Purchase your ticket at the SAAOG Registration Desk in the Grand Ballroom Foyer.
MONDAY, JANUARY 30
EXPERT THEATER | 8:00 – 9:00am
Location: Eisenhower FG
The Current State of Desmoid Tumor Management: Understanding the Desmoid Tumor Etiology and Disease Management
Sponsored by Springworks Therapeutics
SYMPOSIUM | 10:15 – 11:15am
Location: General Session; Grand Ballroom A
vNotes: The Return of Vaginal Surgery
Speaker: Jay Matkins, MD
Hosted by Applied Medical
PRESIDENT’S LUNCHEON IN HONOR OF SAAOG PRESIDENT CAROLYN S. WILSON, MD | 1:05 – 2:05pm
Complimentary for attendees; $115/guest(s)
Make plans to attend the President’s Luncheon, and have the opportunity to connect and interact with the President of SAAOG, Dr. Carolyn Wilson, as well as the rest of the SAAOG leadership. The luncheon provides the perfect opportunity to get up to speed on the latest news around the organization, the board, and to socialize. You must register to attend. (Please note registration is complimentary for attendees; if you plan to bring a guest to the Luncheon, they must have a purchased guest badge.)
Stay tuned for our confirmed symposia programs.
As a new generation medical device company, Applied Medical is committed to improving the affordability and accessibility of high-quality healthcare. We are proud to have a significant and sustainable impact on healthcare by delivering technologies that enhance clinical care, advance minimally invasive surgery, and satisfy the pressing economic needs of our customers. As a result of our dedication to understanding and satisfying our customers’ clinical and fiscal needs, we are a leading provider of breakthrough technologies for multiple specialties, including obstetrics and gynecology. Headquartered in Southern California, Applied Medical is proud to provide our products to more than 75 countries.
Aspira Women’s Health Inc. is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management, and improve gynecologic health outcomes for women. Aspira Women’s Health is particularly focused on solutions that perform broadly across patient types and closing the ethnic disparity gap in ovarian cancer risk assessment. OVA1plus™ combines our FDA-cleared products, OVA1® and OVERA®, to evaluate risk of ovarian malignancy in women with adnexal masses that are planned for surgery. Aspira GenetiX™ testing offers both targeted and comprehensive genetic testing options with a gynecologic focus. With over 10 years of expertise in ovarian cancer risk assessment, Aspira Women’s Health is working to deliver a portfolio of pelvic mass products over a patient’s lifetime with our cutting-edge research and development of women’s health risk assessments driven by proprietary biomarker panels and proprietary machine learning driven algorithms. The next generation of products in development include OVAWatch™ for adnexal masses and EndoCheck™ for endometriosis. To maximize patient and provider access to our suite of solutions, Aspira Women’s Health has recently launched our Aspira Synergy™ technology transfer platform which empowers health systems, academics, regional labs, and physician group labs to conduct genetic and specialty tests in-house. Visit our website for more information at www.aspirawh.com
Black Pearl Beginnings™ was a company founded in 2022. We are focused on women’s health and are located in Scottsdale, AZ. We just launched a new prenatal vitamin called Black Pearl Beginnings™.
Throughout history, Black Pearls have been rich with meaning. They symbolize rare beauty, love, strength, protection, and even fertility. The name perfectly complements the unique dark hue of the soft gel capsule. “Beginnings” is a natural way to complete the product name - as the prenatal vitamin journey for women occurs before, during, and after pregnancy
Avion Pharmaceuticals is a specialty pharmaceutical company that develops and markets a growing portfolio of innovative, branded prescription pharmaceutical and dietary supplements. We specialize in products for women’s health, hematology, endocrinology,
Comprehensive image management and reporting solution: Streamlined and intuitive, the Studycast system provides a single workflow from exam to archive. Add on the optional integration interfaces, and the system goes full circle from order to results. View diagnostic-quality images and loops, quickly generate findings, and digitally sign reports from any Internet-connected device. Then, securely share them with colleagues and patients, route them to your EMR, and archive them in the cloud. View ultrasound images, quickly create complete reports, and share images with the patient on their smartphone. Anywhere. Anytime. Instantly. What if you could securely send images to the patient’s smartphone during their appointment? With the Studycast system, sharing images has never been faster or easier. Studies upload as soon as you complete the exam and are ready to view, interpret, and share in seconds. With just a few clicks, send the patient a secure link to download their images before they even leave the exam room.
No printing. No discs to burn. Just fast, secure image sharing. How easy is that?
Study-specific worksheets and reports for
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. In the United States, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and orthopaedics. For more information, call 1-888-FERRING (1-888-337-7464); visit www.FerringUSA.com”
A global leader in women’s health, Hologic enables people to lead healthier lives everywhere, every day. The Diagnostic Solutions division delivers on this commitment by developing and providing innovative cytology, molecular and perinatal testing. Our Panther®
Mayne Pharma is focused on applying its track record of innovation and success to commercialize branded and generic pharmaceuticals, offering patients better and more accessible medicines. The company has an extensive Women's Health portfolio focused on contraceptives, including its flagship, newly FDA-approved, novel birth control pill. https://reference.medscape.com/drug/nextstellis-estetrol-drospirenone-40...
The ModMed OBGYN suite is a cloud-based, electronic health records (EHR) system designed
to adapt to each doctor’s style of practice, remembering preferences and automatically
suggesting documentation and billing codes. Available on a tablet or the web, EMA®, our EHR,
works seamlessly with our other products and services including Practice Management,
revenue cycle management, ModMed Telehealth, ModMed Pay, patient engagement tools, and
In partnership with forward-thinking providers across the country, Onsite Women’s Health offers comprehensive mammography services with clinical expertise, innovative technology, and proprietary protocols that delivers personalized, convenient breast care for the patient
Organon is a global healthcare company focused on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. For more information, visit www.organon.com and connect with us on LinkedIn and Instagram.
PeriGen is an innovative provider of fetal surveillance systems employing patented, pattern-recognition and obstetrics technologies that empower perinatal clinicians to make confident, real-time decisions about the mothers and babies in their care. Our customer-centric team of clinicians and technologists builds the most advanced systems available to augment obstetric decision-making and improve communications among the clinical team at the point of care, while supporting data flow between healthcare IT systems.
PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. The Vanadis platform is a cell-free DNA analysis solution to enable targeted cfDNA analysis without PCR, instead directly capturing target fragments of chromosomes 21, 18, 13, X & Y and labeling them for counting. With Vanadis, there is no need for expensive and data-intensive steps, common amongst DNA sequencing and microarray-based technologies.
Myovant Sciences and Pfizer aspire to redefine care for women by developing empowering medicines that can change treatment paradigms for various conditions that impact women’s health. By combining Myovant’s commitment to purpose-driven science with Pfizer’s deep heritage and leadership in women’s health, we are uniquely positioned to provide innovative treatments that fulfill significant unmet needs and make a meaningful difference in women’s lives.
Our mission began in 2007 with support of the National Institutes of Health (NIH), to develop and provide the most advanced genetic testing to research institutions and clinical care providers. Since 2011, many of the country's most innovative institutions have relied on us for superior genetic testing such as the NIC, CDC, Harvard University, Stanford University, University of California San Francisco, and MIT.
Pfizer relentlessly pursues breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place.
With nearly 30,000 team members, 18 hospitals, 2,984 beds and more than 300 physician practice sites, Prisma Health serves more than 1.2 million unique patients annually and is the largest not-for-profit healthcare provider in South Carolina. Its goal is to improve the health of all South Carolinians by enhancing clinical quality, the patient experience and access to affordable care, as well as conducting clinical research and training the next generation of medical professionals. For more information, visit PrismaHealth.org.
Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive.
Samsung is transforming the ultrasound experience with the Hera premium product portfolio. From exquisite image clarity and new technologies to advanced ergonomics, Hera delivers ultrasound in a way never seen before. Hera W10 is a familiar console design featuring unprecedented performance with a brand new architecture and state of the art ergonomic design. Hera I10 is re-inventing the ultrasound experience with the introduction of the Hera i10. The “I” represents integration and a first of its kind ergonomic design that helps create an ideal scanning environment and enhanced patient interaction. Finally, Hera W9 is designed to elevate confidence and efficiency, combines premium imaging technology with streamlined workflow for ease of use.
SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for patients with severe rare diseases and cancer. SpringWorks has a differentiated targeted oncology pipeline spanning solid tumors and hematological cancers, including two late-stage clinical trials in rare tumor types as well as several programs addressing highly prevalent, genetically defined cancers. SpringWorks’ strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients with cancer. For more information, visit www.springworkstx.com and follow @SpringWorksTx on Twitter and LinkedIn
Zero Gravity is a manufacturer of LED medical devices that are FDA approved for pain management and skin rejuvenation.
2023 Exhibitor listing coming soon!
Abstract Type: Podium Presentation: All authors selected for a podium presentation were invited to submit a recording of their presentation that they would have delivered from the podium at the live meeting. You can review those that were submitted below.
Abstract Type: Poster Hall: All authors selected for a poster presentation were invited to submit a version of their poster. You can review those that were submitted below.
2023 Confirmed Product Theaters Coming Soon!